The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths
Open accessAbstract
Since the emergence of coronavirus disease 2019 (COVID-19) (formerly known as the 2019 novel coronavirus [2019-nCoV]) in Wuhan, China in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 75,000 cases have been reported in 32 countries/regions, resulting in more than 2000 deaths worldwide. Despite the fact that most COVID-19 cases and mortalities were reported in China, the WHO has declared this outbreak as the sixth public health emergency of international concern. The COVID-19 can present as an asymptomatic carrier state, acute respiratory disease, and pneumonia. Adults represent the population with the highest infection rate; however, neonates, children, and elderly patients can also be infected by SARS-CoV-2. In addition, nosocomial infection of hospitalized patients and healthcare workers, and viral transmission from asymptomatic carriers are possible. The most common finding on chest imaging among patients with pneumonia was ground-glass opacity with bilateral involvement. Severe cases are more likely to be older patients with underlying comorbidities compared to mild cases. Indeed, age and disease severity may be correlated with the outcomes of COVID-19. To date, effective treatment is lacking; however, clinical trials investigating the efficacy of several agents, including remdesivir and chloroquine, are underway in China. Currently, effective infection control intervention is the only way to prevent the spread of SARS-CoV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China
Yang, Y., Lu, Q.-B., Liu, M.-J., Wang, Y.-X., Zhang, A.-R., Jalali, N., Dean, N. E., Longini, I., Halloran, M. E., Xu, B., et al. (2020) · medRxiv · doi:10.1101/2020.02.10.20021675 · Cited by 516
Self-citationRetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · cited 1×
“Initially, approximately half of the cases had Huanan seafood market exposure and animal-to-human transmission was suspected.(12,13) However, fewer cases had exposure to this seafood market and an increasing number of cases demonstrated human-to-human transmission.”
Self-citationClinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationChen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citationWang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Self-citationChan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,403
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105924 · Cited by 6,068
Self-citationFirst case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., Yu, J., Kang, M., Song, Y., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,810
Presumed Asymptomatic Carrier Transmission of COVID-19
Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D.-Y., Chen, L., & Wang, M. (2020) · JAMA · doi:10.1001/jama.2020.2565 · Cited by 4,498
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., Zimmer, T., Thiel, V., Janke, C., Guggemos, W., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001468 · Cited by 4,144
Chen, H., Guo, J., Wang, C., Luo, F., Yu, X., Zhang, W., Li, J., Zhao, D., Xu, D., Gong, Q., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30360-3 · Cited by 3,919
Self-citation(2020) · PubMed · doi:10.3760/cma.j.issn.0254-6450.2020.02.003 · Cited by 3,323
CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)
Chung, M., Bernheim, A., Mei, X., Zhang, N., Huang, M., Zeng, X., Cui, J., Xu, W., Yang, Y., Fayad, Z. A., et al. (2020) · Radiology · doi:10.1148/radiol.2020200230 · Cited by 2,751
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Russell, C. D., Millar, J. E., & Baillie, J. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30317-2 · Cited by 2,008
Coronavirus infections and immune responses
Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., Zhou, P., Pan, P., Wang, W., Hu, D., Liu, X., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25685 · Cited by 1,946
Backer, J. A., Klinkenberg, D., & Wallinga, J. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.5.2000062 · Cited by 1,500
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · PubMed Central · Cited by 1,278
Drug treatment options for the 2019-new coronavirus (2019-nCoV)
Lu, H. (2020) · BioScience Trends · doi:10.5582/bst.2020.01020 · Cited by 1,133
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
Arabi, Y. M., Mandourah, Y., Al-Hameed, F., Sindi, A. A., Almekhlafi, G. A., Hussein, M. A., Jose, J., Pinto, R., Al-Omari, A., Kharaba, A., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201706-1172oc · Cited by 1,122
Liu, J., Liu, Y., Xiang, P., Pu, L., Xiong, H., Li, C., Zhang, M., Tan, J., Xu, Y., Song, R., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02374-0 · Cited by 1,082
Self-citationPan, Y., Guan, H., Zhou, S., Wang, Y., Li, Q., Zhu, T., Hu, Q., & Xia, L. (2020) · European Radiology · doi:10.1007/s00330-020-06731-x · Cited by 999
Self-citationMorse, J. S., Lalonde, T., Xu, S., & Liu, W. R. (2020) · ChemBioChem · doi:10.1002/cbic.202000047 · Cited by 776
Sochacki, T., Jourdain, F., Perrin, Y., Noel, H., Paty, M.-C., de Valk, H., Septfons, A., Simard, F., Fontenille, D., & Roche, B. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.18.30221 · Cited by 735
CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia
Lei, J., Li, J., Li, X., & Qi, X. (2020) · Radiology · doi:10.1148/radiol.2020200236 · Cited by 700
Protecting health-care workers from subclinical coronavirus infection
Chang, D., Xu, H., Rebaza, A., Sharma, L., & Dela Cruz, C. S. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30066-7 · Cited by 664
Yu, P., Zhu, J., Zhang, Z., & Han, Y. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa077 · Cited by 659
Kanne, J. P. (2020) · Radiology · doi:10.1148/radiol.2020200241 · Cited by 658
Are children less susceptible to COVID-19?
Lee, P.-I., Hu, Y.-L., Chen, P.-Y., Huang, Y.-C., & Hsueh, P.-R. (2020) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.02.011 · Cited by 655
Self-citationLee, N., Allen Chan, K. C., Hui, D. S., Ng, E. K. O., Wu, A., Chiu, R. W. K., Wong, V. W. S., Chan, P. K. S., Wong, K. T., Wong, E., et al. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.07.006 · Cited by 636
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
Colson, P., Rolain, J.-M., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105923 · Cited by 468
Patel, A., Jernigan, D. B., 2019-nCoV CDC Response Team, 2019-nCoV CDC Response Team, Abdirizak, F., Abedi, G., Aggarwal, S., Albina, D., Allen, E., Andersen, L., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6905e1 · Cited by 449
Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score
Guo, L., Wei, D., Zhang, X., Wu, Y., Li, Q., Zhou, M., & Qu, J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02752 · Cited by 420
Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV
Lee, P.-I., & Hsueh, P.-R. (2020) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.02.001 · Cited by 327
Self-citationArguments in favour of remdesivir for treating SARS-CoV-2 infections
Ko, W.-C., Rolain, J.-M., Lee, N.-Y., Chen, P.-L., Huang, C.-T., Lee, P.-I., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105933 · Cited by 316
Self-citationZhou, N., Pan, T., Zhang, J., Li, Q., Zhang, X., Bai, C., Huang, F., Peng, T., Zhang, J., Liu, C., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.716100 · Cited by 286
An interim review of the epidemiological characteristics of 2019 novel coronavirus
Ryu, S., & Chun, B. C. (2020) · Epidemiology and Health · doi:10.4178/epih.e2020006 · Cited by 198
Patel, A., & Jernigan, D. B. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15805 · Cited by 197
[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].
(2020) · PubMed · doi:10.3760/cma.j.issn.1001-0939.2020.0019 · Cited by 189
Imaging changes in patients with 2019-nCov
Pan, Y., & Guan, H. (2020) · European Radiology · doi:10.1007/s00330-020-06713-z · Cited by 164
A Locally Transmitted Case of SARS-CoV-2 Infection in Taiwan
Liu, Y.-C., Liao, C.-H., Chang, C.-F., Chou, C.-C., & Lin, Y. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001573 · Cited by 157
Self-citationPre- and Posttreatment Chest CT Findings: 2019 Novel Coronavirus (2019-nCoV) Pneumonia
Duan, Y.-N., & Qin, J. (2020) · Radiology · doi:10.1148/radiol.2020200323 · Cited by 149
Lee, D. T. S., Wing, Y. K., Leung, H. C. M., Sung, J. J. �., Ng, Y., Yiu, G.-C., Chen, R. Y. L., & Chiu, H. F. K. (2004) · Clinical Infectious Diseases · doi:10.1086/424016 · Cited by 141
Nishiura, H., Linton, N. M., & Akhmetzhanov, A. R. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020488 · Cited by 136
2019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China
Huang, W.-H., Teng, L.-C., Yeh, T.-K., Chen, Y.-J., Lo, W.-J., Wu, M.-J., Chin, C.-S., Tsan, Y., Lin, T., Chai, J., et al. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.02.009 · Cited by 87
Balzarini, J. M., Keyaerts, E., Vijgen, L., Egberink, H. F., Clercq, E. D., Ranst, M. A. V., Printsevskaya, S. S., Olsufyeva, E. N., Solovieva, S. E., & PREOBRAZHENSKAYA, M. N. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.03.005 · Cited by 58
Xiao, J., Ma, L., Gao, J., Yang, Z., Xing, X., Zhao, H., Jiao, J., & Li, G. (2004) · PubMed · Cited by 55
Controlling Middle East Respiratory Syndrome: Lessons Learned From Severe Acute Respiratory Syndrome
Yen, M., Schwartz, J. R. L., Wu, J.-S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ648 · Cited by 19
Self-citation
Cited by
Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults
Ludvigsson, J. F. (2020) · Acta Paediatrica · doi:10.1111/apa.15270 · Cited by 2,301
SARS-CoV-2 in wastewater: State of the knowledge and research needs
Kitajima, M., Ahmed, W., Bibby, K., Carducci, A., Gerba, C. P., Hamilton, K. A., Haramoto, E., & Rose, J. B. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139076 · Cited by 759
COVID-19: Immunology and treatment options
Felsenstein, S., Herbert, J. A., McNamara, P. S., & Hedrich, C. M. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108448 · Cited by 669
Harmon, S. A., Sanford, T. H., Xu, S., Turkbey, E. B., Roth, H., Xu, Z., Yang, D., Myronenko, A., Anderson, V., Amalou, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17971-2 · Cited by 587
Acter, T., Uddin, N., Das, J., Akhter, A., Choudhury, T. R., & Kim, S. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138996 · Cited by 575
Metadata
- Authors
- Lai, C.-C., Liu, Y. H., Wang, C.-Y., Wang, Y.-H., Hsueh, S.-C., Yen, M.-Y., Ko, W.-C., & Hsueh, P.-R.
- Venue
- Journal of Microbiology, Immunology and Infection
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 53
- Issue
- 3
- Pages
- 404-412
- ISSN
- 1684-1182 (ISSN-L)
- OpenAlex
- W3009567932
- Cited by
- 935
- References
- 52
- FWCI
- 26.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.